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Discussion
The normal pathway for reduction of methaemoglobin is initiated by cytochrome b5 reductase which catalyses the reduction of cytochrome b5. The reduced cytochrome b5 then transfers an electron non-enzymatically to methaemoglobin.8 The patient and several members of her family showed activities of reductase which were less than that of controls. In the DCIP assay methaemoglobinaemic patients with homozygous deficiency of reductase usually show an activity of about 10% of normal, while their heterozygous (and non-cyanotic) 
